Plakous Therapeutics

Necrotizing Enterocolitis (NEC) is the leading cause of death in babies of very low birth weight. Current treatments are inadequate, and new therapies are difficult to introduce to this population. Plakous Therapeutics is developing a novel therapeutic to prevent neonatal diseases and heal diseases of inflammation, starting with NEC.